{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:42:57Z","timestamp":1782783777791,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["NSTC 113-2320-B-016-004"],"award-info":[{"award-number":["NSTC 113-2320-B-016-004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16am0101012j0005"],"award-info":[{"award-number":["16am0101012j0005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jphs.2025.03.012","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:17:16Z","timestamp":1744370236000},"page":"139-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel lysophosphatidic acid receptor 1 antagonist with high brain penetrability has a curative effect in the empathic pain-related fibromyalgia model"],"prefix":"10.1016","volume":"158","author":[{"given":"Hiroyuki","family":"Neyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Dozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuka","family":"Sahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8002-0137","authenticated-orcid":false,"given":"Hiroshi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jphs.2025.03.012_bib1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nm1060","article-title":"Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling","volume":"10","author":"Inoue","year":"2004","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"10.1016\/j.jphs.2025.03.012_bib2","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/j.pain.0000000000000813","article-title":"Lysophosphatidic acid signaling is the definitive mechanism underlying neuropathic pain","volume":"158","author":"Ueda","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2025.03.012_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101079","article-title":"Pathogenic mechanisms of lipid mediator lysophosphatidic acid in chronic pain","volume":"81","author":"Ueda","year":"2021","journal-title":"Prog Lipid Res"},{"issue":"8","key":"10.1016\/j.jphs.2025.03.012_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081906","article-title":"Lysophosphatidic acid receptor 1- and 3-mediated hyperalgesia and hypoalgesia in diabetic neuropathic pain models in mice","volume":"9","author":"Ueda","year":"2020","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.jphs.2025.03.012_bib5","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1097\/j.pain.0000000000001316","article-title":"Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain","volume":"159","author":"Ueda","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2025.03.012_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2018.07.001","article-title":"Lysophosphatidic acid LPA(1) and LPA(3) receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice","volume":"5","author":"Ueda","year":"2019","journal-title":"Neurobiol Pain"},{"key":"10.1016\/j.jphs.2025.03.012_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ynpai.2017.04.002","article-title":"LPA1 receptor involvement in fibromyalgia-like pain induced by intermittent psychological stress, empathy","volume":"1","author":"Ueda","year":"2017","journal-title":"Neurobiol Pain"},{"issue":"1","key":"10.1016\/j.jphs.2025.03.012_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12010056","article-title":"Fibromyalgia animal models using intermittent cold and psychological stress","volume":"12","author":"Ueda","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.jphs.2025.03.012_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2014.11.020","article-title":"Lysophospholipid receptors in drug discovery","volume":"333","author":"Kihara","year":"2015","journal-title":"Exp Cell Res"},{"issue":"2","key":"10.1016\/j.jphs.2025.03.012_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jphs.2025.03.012_bib11","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"4","author":"Percie du Sert","year":"2020","journal-title":"BMJ Open Sci."},{"issue":"1","key":"10.1016\/j.jphs.2025.03.012_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"issue":"13","key":"10.1016\/j.jphs.2025.03.012_bib13","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1523\/JNEUROSCI.5541-09.2010","article-title":"Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain","volume":"30","author":"Uchida","year":"2010","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.jphs.2025.03.012_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1011107422318","article-title":"Substructure and whole molecule approaches for calculating log P","volume":"15","author":"Mannhold","year":"2001","journal-title":"J Comput Aided Mol Des"}],"updated-by":[{"DOI":"10.1016\/j.jphs.2025.04.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861325000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861325000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:51:55Z","timestamp":1762368715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861325000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1347861325000337"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2025.03.012","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel lysophosphatidic acid receptor 1 antagonist with high brain penetrability has a curative effect in the empathic pain-related fibromyalgia model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2025.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}